Abstract
canSAR (http://cansar.icr.ac.uk) is a public, freely available, integrative translational research and drug discovery knowlegebase. canSAR informs researchers to help solve key bottlenecks in cancer translation and drug discovery. It integrates genomic, protein, pharmacological, drug and chemical data with structural biology, protein networks and unique, comprehensive and orthogonal 'druggability' assessments. canSAR is widely used internationally by academia and industry. Here we describe major enhancements to canSAR including new and expanded data. We also describe the first components of canSARblack-an advanced, responsive, multi-device compatible redesign of canSAR with a question-led interface.
Cite
CITATION STYLE
Coker, E. A., Mitsopoulos, C., Tym, J. E., Komianou, A., Kannas, C., Di Micco, P., … Al-Lazikani, B. (2019). CanSAR: Update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Research, 47(D1), D917–D922. https://doi.org/10.1093/nar/gky1129
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.